Krishna Institute of Medical Sciences Limited Net Assets
Krishna Institute of Medical Sciences Limited net assets. Based on the latest financial reports, Krishna Institute of Medical Sciences Limited (KIMS) has net assets worth Rs25.59 Billion INR (≈ $276.69 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs77.59 Billion ≈ $839.07 Million USD) and total liabilities (Rs52.00 Billion ≈ $562.38 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset growth rate of Krishna Institute of Medical Sciences Li to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs25.59 Billion |
| % of Total Assets | 32.98% |
| Annual Growth Rate | 22.03% |
| 5-Year Change | 81.37% |
| 10-Year Change | 666.42% |
| Growth Volatility | 48.07 |
Net Assets of Krishna Institute of Medical Sciences Limited (2013–2026)
Net assets of Krishna Institute of Medical Sciences Limited from 2013 to 2026. This chart illustrates how Krishna Institute of Medical Sciences Limited's net assets have evolved over time, based on quarterly financial data. See KIMS equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Krishna Institute of Medical Sciences Limited (2013–2026)
The table below shows the annual net assets of Krishna Institute of Medical Sciences Limited from 2013 to 2026. For live market cap and overall valuation, see KIMS company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs25.59 Billion ≈ $276.69 Million |
+5.78% |
| 2025-03-31 | Rs24.19 Billion ≈ $261.58 Million |
+15.55% |
| 2024-03-31 | Rs20.93 Billion ≈ $226.38 Million |
+8.01% |
| 2023-03-31 | Rs19.38 Billion ≈ $209.58 Million |
+37.38% |
| 2022-03-31 | Rs14.11 Billion ≈ $152.56 Million |
+61.00% |
| 2021-03-31 | Rs8.76 Billion ≈ $94.76 Million |
+43.30% |
| 2020-03-31 | Rs6.11 Billion ≈ $66.12 Million |
+7.85% |
| 2019-03-31 | Rs5.67 Billion ≈ $61.31 Million |
+510.14% |
| 2018-03-31 | Rs-1.38 Billion ≈ $-14.95 Million |
-141.41% |
| 2017-03-31 | Rs3.34 Billion ≈ $36.10 Million |
+23.55% |
| 2016-03-31 | Rs2.70 Billion ≈ $29.22 Million |
+10.60% |
| 2015-03-31 | Rs2.44 Billion ≈ $26.42 Million |
+21.16% |
| 2014-03-31 | Rs2.02 Billion ≈ $21.81 Million |
+4.84% |
| 2013-03-31 | Rs1.92 Billion ≈ $20.80 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Krishna Institute of Medical Sciences Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1048.3% over the analyzed period, indicating profitable operations and earnings retention.
Krishna Institute of Medical Sciences Limited Net Assets Breakdown (March 2026)
Krishna Institute of Medical Sciences Limited net assets breakdown by equity component as of March 2026.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs11.76 Billion | 52.30% |
| Common Stock | Rs800.00 Million | 3.56% |
| Other Components | Rs9.92 Billion | 44.14% |
| Total Equity | Rs22.47 Billion | 100.00% |
Krishna Institute of Medical Sciences Limited Competitors by Market Cap
The table below lists competitors of Krishna Institute of Medical Sciences Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jb Financial
KO:175330
|
$3.16 Billion |
|
Atkore International Group Inc
NYSE:ATKR
|
$3.16 Billion |
|
Sejong Telecom Inc
KQ:036630
|
$3.17 Billion |
|
IPG Photonics Corporation
NASDAQ:IPGP
|
$3.17 Billion |
|
Anhui Zhongding Sealing Parts Co Ltd
SHE:000887
|
$3.16 Billion |
|
X-Energy, Inc. Class A Common Stock
NASDAQ:XE
|
$3.16 Billion |
|
TOMRA SYSTEMS ADR/1 NK 1
F:TMR0
|
$3.15 Billion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
$3.15 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Krishna Institute of Medical Sciences Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 21,378,000,000 to 22,474,000,000, a change of 1,096,000,000 (5.1%).
- Net income of 2,414,000,000 contributed positively to equity growth.
- New share issuances of 288,000,000 increased equity.
- Other comprehensive income increased equity by 114,000,000.
- Other factors decreased equity by 1,720,000,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs2.41 Billion | +10.74% |
| Share Issuances | Rs288.00 Million | +1.28% |
| Other Comprehensive Income | Rs114.00 Million | +0.51% |
| Other Changes | Rs-1.72 Billion | -7.65% |
| Total Change | Rs- | 5.13% |
Book Value vs Market Value Analysis
This analysis compares Krishna Institute of Medical Sciences Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.01x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 133.21x to 13.01x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-03-31 | Rs5.48 | Rs730.50 | x |
| 2014-03-31 | Rs5.62 | Rs730.50 | x |
| 2015-03-31 | Rs6.78 | Rs730.50 | x |
| 2016-03-31 | Rs7.48 | Rs730.50 | x |
| 2017-03-31 | Rs9.24 | Rs730.50 | x |
| 2018-03-31 | Rs-4.18 | Rs730.50 | x |
| 2019-03-31 | Rs13.51 | Rs730.50 | x |
| 2020-03-31 | Rs15.93 | Rs730.50 | x |
| 2021-03-31 | Rs22.69 | Rs730.50 | x |
| 2022-03-31 | Rs34.93 | Rs730.50 | x |
| 2023-03-31 | Rs41.72 | Rs730.50 | x |
| 2024-03-31 | Rs45.69 | Rs730.50 | x |
| 2025-03-31 | Rs53.43 | Rs730.50 | x |
| 2026-03-31 | Rs56.14 | Rs730.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Krishna Institute of Medical Sciences Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.74%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.18%
- • Asset Turnover: 0.50x
- • Equity Multiplier: 3.45x
- Recent ROE (10.74%) is below the historical average (11.43%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 9.82% | 6.42% | 0.52x | 2.94x | Rs-3.52 Million |
| 2014 | 3.54% | 1.95% | 0.56x | 3.24x | Rs-126.85 Million |
| 2015 | 2.35% | 1.33% | 0.64x | 2.76x | Rs-182.37 Million |
| 2016 | 10.11% | 5.20% | 0.77x | 2.53x | Rs2.79 Million |
| 2017 | 9.97% | 5.74% | 0.73x | 2.37x | Rs-872.00K |
| 2018 | 0.00% | -7.14% | 0.69x | 0.00x | Rs-315.11 Million |
| 2019 | -8.84% | -5.20% | 0.82x | 2.07x | Rs-1.02 Billion |
| 2020 | 19.93% | 10.62% | 0.94x | 2.00x | Rs593.71 Million |
| 2021 | 23.30% | 15.33% | 0.91x | 1.66x | Rs1.15 Billion |
| 2022 | 23.98% | 20.15% | 0.87x | 1.37x | Rs1.94 Billion |
| 2023 | 20.14% | 15.52% | 0.74x | 1.76x | Rs1.69 Billion |
| 2024 | 16.96% | 12.53% | 0.64x | 2.11x | Rs1.27 Billion |
| 2025 | 17.99% | 12.80% | 0.52x | 2.68x | Rs1.71 Billion |
| 2026 | 10.74% | 6.18% | 0.50x | 3.45x | Rs166.60 Million |
Industry Comparison
This section compares Krishna Institute of Medical Sciences Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $10,699,448,444
- Average return on equity (ROE) among peers: 0.84%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Krishna Institute of Medical Sciences Limited (KIMS) | Rs25.59 Billion | 9.82% | 2.03x | $3.16 Billion |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $29.95 Billion | 11.35% | 0.79x | $13.12 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $13.71 Billion | 12.97% | 1.11x | $6.42 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $1.01 Billion | 7.52% | 1.28x | $122.16 Million |
| Healthcare Global Enterprises Limited (HCG) | $8.65 Billion | 5.57% | 2.13x | $987.60 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $15.44 Billion | 12.58% | 0.54x | $932.07 Million |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $493.84 Million | -4.01% | 0.14x | $24.44 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $11.28 Billion | -2.00% | 1.70x | $9.43 Billion |
| Max India Limited (MAXIND) | $3.59 Billion | -39.14% | 0.76x | $87.92 Million |
| Global Health Limited (MEDANTA) | $12.17 Billion | 2.70% | 0.63x | $3.85 Billion |
About Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and g… Read more